Showing results (301-310 of 2,227) with videos related to

Sort By:
Pageof 223
The Journal of Veterinary Medical Science|April 27, 2004
Prevalence of anti-Toxoplasma gondii antibody in hunter-killed wild boars, Sus scrofa leucomystax, on Amakusa Island, Kumamoto Prefecture, JapanTakashi Shiibashi, Koichiro Narasaki, Motonobu Yoshida, et al.
Pediatric Neurology|March 31, 2005
A new mutation of IGHMBP2 gene in spinal muscular atrophy with respiratory distress type 1Nobutada Tachi, Sin Kikuchi, Naoki Kozuka, et al.
British Journal of Haematology|July 15, 2009
von Willebrand factor protects the Ca2+-dependent structure of the factor VIII light chainMasahiro Takeyama, Keiji Nogami, Masahiro Okuda, et al.
Nanotechnology|July 29, 2009
Converting an insulating silicon nanochain to a conducting carbon nanotube by electrical breakdownT Nogami, Y Ohno, S Ichikawa, et al.
Thrombosis and Haemostasis|September 28, 2011
Interactions between residues 2228-2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formationT Soeda, K Nogami, K Ogiwara, et al.
Thrombosis and Haemostasis|January 12, 2012
A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodiesTomoko Matsumoto, Keiji Nogami, Kenichi Ogiwara, et al.
International Journal of Hematology|April 2, 2014
Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe hemophilia A patients with inhibitorKenichi Ogiwara, Keiji Nogami, Tomoko Matsumoto, et al.
Die Pharmazie|March 20, 2014
Pharmacokinetic evaluation of intraperitoneal doxorubicin in ratsK Nagai, S Nogami, H Egusa, et al.
International Journal of Hematology|December 7, 2014
Optimization of the automated, CS-2000i™ method for measuring low levels of von Willebrand factor ristocetin cofactor activity (VWF:RCo)Tomoko Matsumoto, Keiji Nogami, Masahiro Okuda, et al.
International Journal of Pharmaceutics|November 10, 2020
Design of a pH-responsive oral gel formulation based on the matrix systems of gelatin/hydroxypropyl methylcellulose phthalate for controlled drug releaseSatoshi Nogami, Hiromasa Uchiyama, Kazunori Kadota, et al.
Pageof 223